Tennessee Bills

Bill Title Introduced Latest Action
HB 656 (111th Regular Session (2019-2020))
Drugs, Prescription - As introduced, specifies that within 10 days of receiving the nonresidential buprenorphine guidelines and standards a health-related board that licenses any practitioner authorized to prescribe buprenorphine must post such guidelines and standards on the board's website. - Amends TCA Title 33; Title 53; Title 63 and Title 68.
Feb 04 2019 Filed For Introduction
Apr 18 2019
SB 1060 (111th Regular Session (2019-2020))
Drugs, Prescription - As introduced, specifies that within 10 days of receiving the nonresidential buprenorphine guidelines and standards a health-related board that licenses any practitioner authorized to prescribe buprenorphine must post such guidelines and standards on the board's website. - Amends TCA Title 33; Title 53; Title 63 and Title 68.
Feb 04 2019 Filed For Introduction
Apr 18 2019
SB 1215 (111th Regular Session (2019-2020))
Drugs, Prescription - As introduced, removes restrictions on coverage of off-label drugs by insurers; removes definitions of medical literature and standard reference compendia. - Amends TCA Title 56; Title 63 and Title 71.
Feb 06 2019 Filed For Introduction
Apr 16 2019
HB 1010 (111th Regular Session (2019-2020))
Drugs, Prescription - As introduced, removes restrictions on coverage of off-label drugs by insurers; removes definitions of medical literature and standard reference compendia. - Amends TCA Title 56; Title 63 and Title 71.
Feb 06 2019 Intro.
Apr 16 2019
SB 810 (111th Regular Session (2019-2020))
Drugs, Prescription - As enacted, makes various changes concerning the prescription of certain Scheduled controlled substances. - Amends TCA Title 53, Chapter 10, Part 3; Title 63, Chapter 1, Part 1 and Title 63, Chapter 1, Part 4.
Feb 05 2019 Filed For Introduction
Apr 15 2019
HB 843 (111th Regular Session (2019-2020))
Drugs, Prescription - As enacted, makes various changes concerning the prescription of certain Scheduled controlled substances. - Amends TCA Title 53, Chapter 10, Part 3; Title 63, Chapter 1, Part 1 and Title 63, Chapter 1, Part 4.
Feb 05 2019 Filed For Introduction
Apr 15 2019
HB 364 (111th Regular Session (2019-2020))
Drugs, Prescription - As introduced, requires that Schedule II opioids, Schedule II stimulants, and Schedule IV benzodiazepines be dispensed in a lockable vial; provides exceptions where it is not practicable to dispense the controlled substance in a lockable vial or there is a request from the user not to do so. - Amends TCA Title 53 and Title 63.
Jan 31 2019 Filed For Introduction
Apr 10 2019
SB 475 (111th Regular Session (2019-2020))
Drugs, Prescription - As introduced, requires that Schedule II opioids, Schedule II stimulants, and Schedule IV benzodiazepines be dispensed in a lockable vial; provides exceptions where it is not practicable to dispense the controlled substance in a lockable vial or there is a request from the user not to do so. - Amends TCA Title 53 and Title 63.
Jan 31 2019 Filed For Introduction
Apr 10 2019
HB 887 (111th Regular Session (2019-2020))
Drugs, Prescription - As introduced, enacts the "Prescription Drug Fair Pricing Act." - Amends TCA Title 4; Title 53; Title 56; Title 63; Title 68 and Title 71.
Feb 05 2019 Filed For Introduction
Apr 09 2019
SB 963 (111th Regular Session (2019-2020))
Drugs, Prescription - As introduced, enacts the "Prescription Drug Fair Pricing Act." - Amends TCA Title 4; Title 53; Title 56; Title 63; Title 68 and Title 71.
Feb 05 2019 Filed For Introduction
Apr 09 2019
SB 202 (111th Regular Session (2019-2020))
Drugs, Prescription - As introduced, requires that Schedule II opioids, Schedule II stimulants, and Schedule IV benzodiazepines be dispensed in a lockable vial; provides exceptions where it is not practicable to dispense the controlled substance in a lockable vial or there is a request from the user not to do so. - Amends TCA Title 53 and Title 63.
Jan 29 2019 Withdrawn.
Jan 29 2019
HB 2220 (110th Regular Session (2017-2018))
Drugs, Prescription - As enacted, authorizes a pharmaceutical manufacturer or its representatives to engage in truthful promotion of off-label uses. - Amends TCA Title 4; Title 7; Title 33; Title 53; Title 63; Title 68 and Title 71.
Jan 31 2018 Filed For Intro.
May 08 2018
SB 2361 (110th Regular Session (2017-2018))
Drugs, Prescription - As enacted, authorizes a pharmaceutical manufacturer or its representatives to engage in truthful promotion of off-label uses. - Amends TCA Title 4; Title 7; Title 33; Title 53; Title 63; Title 68 and Title 71.
Jan 31 2018 Filed For Intro.
May 08 2018
HB 2221 (110th Regular Session (2017-2018))
Drugs, Prescription - As introduced, requires the commissioner of health to study issues related to responses by health insurance entities and healthcare providers to the implementation of the Tennessee Prescription Safety Act of 2016, Chapter 1002 of the Public Acts of 2016; requires the commissioner to report the findings and any recommendations arising out of the study to the health committee of the house of representatives and the health and welfare committee of the senate on or before January 15, 2019. - Amends TCA Title 53; Title 56; Title 63 and Title 71.
Jan 31 2018 Filed For Intro.
Apr 24 2018
SB 2565 (110th Regular Session (2017-2018))
Drugs, Prescription - As introduced, requires the commissioner of health to study issues related to responses by health insurance entities and healthcare providers to the implementation of the Tennessee Prescription Safety Act of 2016, Chapter 1002 of the Public Acts of 2016; requires the commissioner to report the findings and any recommendations arising out of the study to the health committee of the house of representatives and the health and welfare committee of the senate on or before January 15, 2019. - Amends TCA Title 53; Title 56; Title 63 and Title 71.
Jan 31 2018 Filed For Intro.
Apr 24 2018
HB 2618 (110th Regular Session (2017-2018))
Drugs, Prescription - As introduced, creates sales tax of ten cents per opioid pill dispensed pursuant to prescription; collected tax to be allocated for drug education, prevention, and treatment, including drug courts. - Amends TCA Title 16, Chapter 22; Title 16, Chapter 6 and Title 67.
Feb 01 2018 Filed For Intro.
Apr 18 2018
SB 2444 (110th Regular Session (2017-2018))
Drugs, Prescription - As introduced, creates sales tax of ten cents per opioid pill dispensed pursuant to prescription; collected tax to be allocated for drug education, prevention, and treatment, including drug courts. - Amends TCA Title 16, Chapter 22; Title 16, Chapter 6 and Title 67.
Feb 01 2018 Introduced, Passed On First Consideration
Apr 18 2018
SB 2415 (110th Regular Session (2017-2018))
Drugs, Prescription - As introduced, requires the comptroller of the treasury to study the process utilized by the state to purchase prescription drugs by looking at the role of pharmacy benefits managers, the role of co-payments in drug costs to the consumer and the state, and the desirability of a bid process approved by the general assembly; requires the comptroller to report to the health committee of the house of representatives and the health and welfare committee of the senate on or before January 15, 2019. - Amends TCA Title 4; Title 8; Title 56 and Title 71.
Feb 01 2018 Introduced, Passed On First Consideration
Mar 28 2018
HB 2466 (110th Regular Session (2017-2018))
Drugs, Prescription - As introduced, requires the comptroller of the treasury to study the process utilized by the state to purchase prescription drugs by looking at the role of pharmacy benefits managers, the role of co-payments in drug costs to the consumer and the state, and the desirability of a bid process approved by the general assembly; requires the comptroller to report to the health committee of the house of representatives and the health and welfare committee of the senate on or before January 15, 2019. - Amends TCA Title 4; Title 8; Title 56 and Title 71.
Feb 01 2018 Intro.
Mar 28 2018
SB 2222 (110th Regular Session (2017-2018))
Drugs, Prescription - As introduced, directs the commissioner of health to study issues related to healthcare access and healthcare status of populations affected by the implementation of the Addiction Treatment Act of 2015, Chapter 396 of the Public Acts of 2015; the commissioner shall report the findings and any recommendations arising out of the study to the health committee of the house of representatives and the health and welfare committee of the senate on or before January 15, 2019. - Amends TCA Title 33; Title 53; Title 63 and Title 68.
Jan 18 2018 Filed For Intro.
Mar 14 2018

Showing 1 to 20 of 48 bills